Life
Briefing: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial
Strategic angle: Xenon Pharmaceuticals reported significant reduction in seizure frequency with its new treatment compared to placebo.
Editorial Staff about 1 month ago